Power Law company profile

InSilico Medicine

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2025 Unicorn

Develops an AI platform for drug development to treat cancer and age-related diseases

Valuation

$4.07B

Market cap · May/2026

Revenue

$56M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

31 investors on InSilico Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Deep Knowledge Ventures

Series A 6 investors entered at this stage

Juvenescence

Bold Capital Partners

A-Level Capital

Jim Mellon

Pavilion Capital Partners

WuXi AppTec

Series B+ 24 investors entered at this stage

Formic Ventures

Qiming Venture Partners

BHR Partners

Mirae Asset Capital

Prosperity7 Ventures

Lilly Asia Ventures

Deerfield

Shanghai Pudong Venture Capital

Value Partners

Maison Capital

Xi Venture Capital

Alex Zhavoronkov

Sage Partners

Lake Bleu Capital

Baidu Ventures

CPE

F-Prime

President International Development Corporation

Warburg Pincus

Sinovation Ventures

Global footprint

Where InSilico Medicine has talent and traffic

AI talent share

4.6% of workforce is AI talent
(13 of 285 staff)

Core AI82.81%

Other AI51.75%

Non-AI workforce27295.44%

Workforce by country

24 countries with
team presence

🇨🇳 China34.5%

🇦🇪 United Arab Emirates20.6%

🇺🇸 United States12.8%

🇭🇰 Hong Kong12.4%

🇨🇦 Canada5.8%

Top 5 of 24 shown

Web traffic by country

58K monthly visits
across markets

🇺🇸 United States26%

🇦🇺 Australia10%

🇮🇳 India9.7%

🇬🇧 United Kingdom6.6%

🏳️ Korea6.2%

Top 5 markets shown

Patent intelligence

$18M patent portfolio · 166 active families

Estimated portfolio value

$18M

0.45% of market cap · comparable to top peer Sinovent ($17M)

166 active patent families

Where InSilico Medicine innovates Pharmaceutical SubstancesPharmaceutical medicineCo carbon monoxideCarbon monoxide detectorSmoke Emission

Where InSilico Medicine concentrates vs peers

Each axis is a top-10 topic across InSilico Medicine and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about InSilico Medicine

An AI-synthesized read of the highest-engagement posts about InSilico Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See InSilico Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles